Kirchgraber Paul R | CEO, Covance Drug Development | Mon Feb 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) | Option Exercise | 182.51 | 3000 | 547530 | 17069 | Feb 23 09:54 AM |
Kirchgraber Paul R | CEO, Covance Drug Development | Mon Feb 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) | Sale | 250.58 | 8000 | 2004675 | 9069 | Feb 23 09:54 AM |
Schroeder Mark S | EVP, President-Diagnostics Lab | Mon Feb 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time) | Sale | 247.63 | 309 | 76518 | 6687 | Feb 16 12:51 PM |
Schroeder Mark S | EVP, President-Diagnostics Lab | Mon Feb 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time) | Sale | 243.01 | 409 | 99391 | 6687 | Feb 09 09:04 AM |
van der Vaart Sandra D | EVP, Chief Legal Officer | Mon Feb 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time) | Sale | 243.01 | 219 | 53219 | 5341 | Feb 09 09:27 AM |
Schroeder Mark S | EVP, President-Diagnostics Lab | Thu Feb 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time) | Sale | 253.9 | 324 | 82264 | 6687 | Feb 06 03:51 PM |
van der Vaart Sandra D | EVP, Chief Legal Officer | Thu Feb 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time) | Sale | 253.9 | 173 | 43925 | 5341 | Feb 06 03:56 PM |
Schroeder Mark S | EVP, President-Diagnostics Lab | Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) | Sale | 232.67 | 1116 | 259660 | 6687 | Nov 10 08:40 AM |
EISENBERG GLENN A | Chief Financial Officer, EVP | Mon Sep 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) | Sale | 210.62 | 25000 | 5265576 | 27158 | Sep 28 09:12 AM |
Caveney Brian J | EVP, President of Diagnostics | Wed Sep 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time) | Buy | 231.2 | 44 | 10251 | 14282 | Sep 13 11:39 AM |